Title VII Improving Access to Innovative Medical Therapies
E87674
Title VII Improving Access to Innovative Medical Therapies is a section of U.S. health reform law that expands and streamlines patient access to cutting-edge drugs, biologics, and related treatments.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Title VII Improving Access to Innovative Medical Therapies canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T735132 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Title VII Improving Access to Innovative Medical Therapies Context triple: [Affordable Care Act, containsTitle, Title VII Improving Access to Innovative Medical Therapies]
-
A.
Ryan Haight Online Pharmacy Consumer Protection Act of 2008
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 is a U.S. federal law that regulates internet pharmacies by requiring valid prescriptions and in-person medical evaluations before dispensing controlled substances online.
-
B.
Clinical Practices of the University of Pennsylvania
Clinical Practices of the University of Pennsylvania is the faculty practice plan and outpatient clinical arm of Penn Medicine, providing patient care across a wide range of specialties in collaboration with the University of Pennsylvania’s health system.
-
C.
National Cancer Act of 1971
The National Cancer Act of 1971 is a landmark U.S. law that greatly expanded federal funding and coordination for cancer research, prevention, and treatment, helping launch the modern "war on cancer."
-
D.
Medical Act 1983
The Medical Act 1983 is a key piece of UK legislation that regulates the medical profession, including the registration and oversight of doctors, primarily through the powers it grants to the General Medical Council.
-
E.
Bayh–Dole Act
The Bayh–Dole Act is a landmark 1980 U.S. law that allows universities, small businesses, and other institutions to retain ownership of inventions developed with federal funding, spurring technology transfer and commercialization.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Title VII Improving Access to Innovative Medical Therapies Target entity description: Title VII Improving Access to Innovative Medical Therapies is a section of U.S. health reform law that expands and streamlines patient access to cutting-edge drugs, biologics, and related treatments.
-
A.
Ryan Haight Online Pharmacy Consumer Protection Act of 2008
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 is a U.S. federal law that regulates internet pharmacies by requiring valid prescriptions and in-person medical evaluations before dispensing controlled substances online.
-
B.
Clinical Practices of the University of Pennsylvania
Clinical Practices of the University of Pennsylvania is the faculty practice plan and outpatient clinical arm of Penn Medicine, providing patient care across a wide range of specialties in collaboration with the University of Pennsylvania’s health system.
-
C.
National Cancer Act of 1971
The National Cancer Act of 1971 is a landmark U.S. law that greatly expanded federal funding and coordination for cancer research, prevention, and treatment, helping launch the modern "war on cancer."
-
D.
Medical Act 1983
The Medical Act 1983 is a key piece of UK legislation that regulates the medical profession, including the registration and oversight of doctors, primarily through the powers it grants to the General Medical Council.
-
E.
Bayh–Dole Act
The Bayh–Dole Act is a landmark 1980 U.S. law that allows universities, small businesses, and other institutions to retain ownership of inventions developed with federal funding, spurring technology transfer and commercialization.
- F. None of above. chosen
Statements (25)
| Predicate | Object |
|---|---|
| instanceOf |
provision of U.S. health reform law
ⓘ
section of federal statute ⓘ |
| appliesTo | patients in the United States ⓘ |
| benefits | patients needing cutting-edge treatments ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| focusesOn |
improving access to innovative therapies
ⓘ
streamlining regulatory processes for therapies ⓘ |
| goal |
expand patient access to innovative medical therapies
ⓘ
streamline patient access to innovative medical therapies ⓘ |
| hasTitleNumber | Title VII ⓘ |
| jurisdiction | federal ⓘ |
| language | English ⓘ |
| legalSystem | United States federal law ⓘ |
| partOf |
Affordable Care Act
ⓘ
surface form:
U.S. health reform law
|
| regulates |
access pathways for biologic products
ⓘ
access pathways for cutting-edge drugs ⓘ access pathways for related medical treatments ⓘ |
| sector | health care ⓘ |
| subjectMatter |
access to innovative medical therapies
ⓘ
biologics ⓘ drugs ⓘ medical treatments ⓘ |
| typeOfTherapiesCovered |
innovative biologics
ⓘ
innovative drugs ⓘ related medical therapies ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Title VII Improving Access to Innovative Medical Therapies Description of subject: Title VII Improving Access to Innovative Medical Therapies is a section of U.S. health reform law that expands and streamlines patient access to cutting-edge drugs, biologics, and related treatments.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.